Drug class

Antiviral-HIV(Antiretroviral) Nucleoside/-tide RT Inhibitors

Antiviral-HIV (antiretroviral) nucleoside and nucleotide reverse transcriptase inhibitors, commonly abbreviated as NRTIs or NtRTIs, are a foundational class of medications used in combination antiretroviral therapy. Read more about Antiviral-HIV(Antiretroviral) Nucleoside/-tide RT Inhibitors

58 drugs in this class 29 manufacturers

Advertisement

Drugs in Antiviral-HIV(Antiretroviral) Nucleoside/-tide RT Inhibitors

Showing 55–58 of 58 drugs

LAMIVUDINE

ANTIVIRAL-HIV(ANTIRETROVIRAL) NUCLEOSIDE/-TIDE RT INHIBITORS · HIV INFECTION
CHARTWELL GOVER
Filter & compare in the drug finder → Opens the drug finder with Antiviral-HIV(Antiretroviral) Nucleoside/-tide RT Inhibitors preselected. Add indication or manufacturer filters there.

About Antiviral-HIV(Antiretroviral) Nucleoside/-tide RT Inhibitors.

Antiviral-HIV (antiretroviral) nucleoside and nucleotide reverse transcriptase inhibitors, commonly abbreviated as NRTIs or NtRTIs, are a foundational class of medications used in combination antiretroviral therapy.

These agents function as structural analogues of natural purine or pyrimidine deoxynucleosides, which require intracellular phosphorylation to become active and subsequently compete for incorporation into growing viral DNA strands.

Lacking an essential 3'-hydroxyl group, they inhibit the viral reverse transcriptase enzyme and cause premature chain termination, thereby halting the transcription of viral RNA into proviral DNA and preventing replication.

NRTIs serve as a cornerstone treatment backbone for human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2) infections, pre- and post-exposure prophylaxis against HIV, and, in certain cases, chronic hepatitis B virus (HBV) infection.